CK2 inhibitor | B2935

CK2 inhibitor selectively inhibits casein kinase 2 (CK2) with an IC₅₀ of 0.125 μM. CK2 is a potential protein kinase target for the development of antitumor, antiviral and anti-inflammatory drugs.

CK2 inhibitor selectively inhibits casein kinase 2 (CK2) with an IC₅₀ of 0.125 μM. CK2 is a potential protein kinase target for the development of antitumor, antiviral and anti-inflammatory drugs.

B2935 | CK2 inhibitor DataSheet

Alternate Name/Synonyms: 3-{[5-(4-ethoxyphenyl)thieno[2,3-d]pyrimidin-4-yl]thio}propanoic acid

Appearance: Solid

Formulation:

CAS Number: 1181227-92-8

Structure Available?: True

Peptide sequence:

Salt Form: false

Molecular Formula: C₁₇H₁₆N₂O₃S₂

Molecular Weight: 360.45

Cell-Permeable?: True

Purity: 95%

Solubilities: Soluble in in DMSO

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: An inhibitor of CK2

MDL Number:

PubChem CID:

SMILES: O=C(O)CCSC1=C(C(C2=CC=C(OCC)C=C2)=CS3)C3=NC=N1

InChi: InChI=1S/C17H16N2O3S2/c1-2-22-12-5-3-11(4-6-12)13-9-24-17-15(13)16(18-10-19-17)23-8-7-14(20)21/h3-6,9-10H,2,7-8H2,1H3,(H,20,21)

InChi Key: BRXZQBGAUIEEBL-UHFFFAOYSA-N